Psychometric validation of the Standard Tests for Asthma, Allergic Rhinitis, and Chronic Rhinosinusitis in the United States

IF 5.8 2区医学 Q1 ALLERGY

Annals of Allergy Asthma & Immunology Pub Date : 2025-06-01 DOI:10.1016/j.anai.2025.02.016

Mandy K. Salmon MD , Priya Arya BS , Vibeke Backer MD, DMSci , Kasper Aanaes MD, PhD , Christian Korsgaard Pedersen MD , Johan Hellgren PhD , Christian von Buchwald MD, DMSci , James N. Palmer MD

{"title":"Psychometric validation of the Standard Tests for Asthma, Allergic Rhinitis, and Chronic Rhinosinusitis in the United States","authors":"Mandy K. Salmon MD , Priya Arya BS , Vibeke Backer MD, DMSci , Kasper Aanaes MD, PhD , Christian Korsgaard Pedersen MD , Johan Hellgren PhD , Christian von Buchwald MD, DMSci , James N. Palmer MD","doi":"10.1016/j.anai.2025.02.016","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Chronic rhinosinusitis with nasal polyposis is an inflammatory disease associated with type 2 inflammation, which is present in lower airway disease (asthma). Current tools used to track symptoms and quality-of-life burden of disease, such as the 22-item Sinonasal Outcome Test (SNOT-22), lack specificity in the symptoms evaluated.</div></div><div><h3>Objective</h3><div>To combat this shortcoming, we validated a new survey, Standard Tests for Asthma, Allergic Rhinitis, and Chronic Rhinosinusitis (STARR-15), in a population of US patients with chronic rhinosinusitis with nasal polyposis.</div></div><div><h3>Methods</h3><div>In this project, STARR-15 was tested in a population of patients with chronic rhinosinusitis with nasal polyposis at a single tertiary care center in the United States. The survey was also compared with a corresponding population of patients with chronic rhinosinusitis without nasal polyps from the same institution.</div></div><div><h3>Results</h3><div>The survey was assessed within the population of patients with chronic rhinosinusitis with nasal polyposis and found to demonstrate good test-retest reliability with an intraclass correlation coefficient of 0.93. The survey was internally valid, with Cronbach alpha of 0.85. Furthermore, the survey was assessed for external validity by comparing it with the SNOT-22. STARR-15 correlated positively with the SNOT-22, with a Pearson coefficient of 0.77.</div></div><div><h3>Conclusion</h3><div>This work has implications in helping follow patient symptoms over time for patients who have not only chronic rhinosinusitis with nasal polyps but also other inflammatory conditions of the lower airways. It also has potential to be used as a screening tool for patients with chronic rhinosinusitis, asthma, and allergic rhinitis.</div></div>","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"134 6","pages":"Pages 671-675"},"PeriodicalIF":5.8000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Allergy Asthma & Immunology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S108112062500095X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Chronic rhinosinusitis with nasal polyposis is an inflammatory disease associated with type 2 inflammation, which is present in lower airway disease (asthma). Current tools used to track symptoms and quality-of-life burden of disease, such as the 22-item Sinonasal Outcome Test (SNOT-22), lack specificity in the symptoms evaluated.

Objective

To combat this shortcoming, we validated a new survey, Standard Tests for Asthma, Allergic Rhinitis, and Chronic Rhinosinusitis (STARR-15), in a population of US patients with chronic rhinosinusitis with nasal polyposis.

Methods

In this project, STARR-15 was tested in a population of patients with chronic rhinosinusitis with nasal polyposis at a single tertiary care center in the United States. The survey was also compared with a corresponding population of patients with chronic rhinosinusitis without nasal polyps from the same institution.

Results

The survey was assessed within the population of patients with chronic rhinosinusitis with nasal polyposis and found to demonstrate good test-retest reliability with an intraclass correlation coefficient of 0.93. The survey was internally valid, with Cronbach alpha of 0.85. Furthermore, the survey was assessed for external validity by comparing it with the SNOT-22. STARR-15 correlated positively with the SNOT-22, with a Pearson coefficient of 0.77.

Conclusion

This work has implications in helping follow patient symptoms over time for patients who have not only chronic rhinosinusitis with nasal polyps but also other inflammatory conditions of the lower airways. It also has potential to be used as a screening tool for patients with chronic rhinosinusitis, asthma, and allergic rhinitis.

查看原文本刊更多论文

STARR-15在美国的心理测量验证。

背景：慢性鼻窦炎合并鼻息肉病是一种与2型炎症相关的炎症性疾病，存在于下气道疾病（哮喘）中。目前用于跟踪疾病症状和生活质量负担的工具，如22项鼻窦结局测试（SNOT-22），在评估的症状中缺乏特异性。目的：为了克服这一缺点，我们验证了一项新的调查，哮喘，过敏性鼻炎和慢性鼻窦炎的标准测试（STARR-15），在美国慢性鼻窦炎合并鼻息肉病患者中进行。方法：在这个项目中，STARR-15在美国单一三级保健中心的慢性鼻窦炎鼻息肉患者群体中进行了测试。该调查还与来自同一机构的慢性鼻窦炎无鼻息肉患者的相应人群进行了比较。结果：该调查在合并鼻息肉的慢性鼻窦炎患者人群中进行了评估，发现具有良好的重测信度，类内相关系数为0.93。该调查是内部有效的，Cronbach alpha为0.85。此外，通过与SNOT-22进行比较，评估了调查的外部效度。STARR-15与SNOT-22呈正相关，Pearson系数为0.77。结论：这项工作有助于长期跟踪患有慢性鼻窦炎伴鼻息肉的患者的症状，同时也有助于其他下气道炎症的患者。此外，它还可能被用作慢性鼻窦炎、哮喘和过敏性鼻炎患者的筛查工具。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Annals of Allergy Asthma & Immunology 医学-过敏

CiteScore

6.50

自引率

6.80%

发文量

437

审稿时长

33 days

期刊介绍： Annals of Allergy, Asthma & Immunology is a scholarly medical journal published monthly by the American College of Allergy, Asthma & Immunology. The purpose of Annals is to serve as an objective evidence-based forum for the allergy/immunology specialist to keep up to date on current clinical science (both research and practice-based) in the fields of allergy, asthma, and immunology. The emphasis of the journal will be to provide clinical and research information that is readily applicable to both the clinician and the researcher. Each issue of the Annals shall also provide opportunities to participate in accredited continuing medical education activities to enhance overall clinical proficiency.